- $1.98bn
- $7.66bn
- $2.56bn
- 48
- 87
- 41
- 60
2019 March 31st | 2020 March 31st | R2021 March 31st | R2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,068 | 2,309 | 1,921 | 2,417 | 2,556 |
Cost of Revenue | |||||
Gross Profit | 531 | 700 | 565 | 706 | 721 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2,129 | 2,271 | 1,967 | 2,530 | 2,712 |
Operating Profit | -60.6 | 38.4 | -46 | -113 | -156 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -107 | 1.43 | -78.2 | -138 | -162 |
Provision for Income Taxes | |||||
Net Income After Taxes | -66.5 | 9.34 | -67 | -101 | -212 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -67.6 | -0.212 | 3.69 | -15.5 | 1,085 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -67.6 | -0.212 | 3.69 | -15.5 | 1,085 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.13 | -0.003 | -1.2 | -1.5 | -2.87 |